Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer.
L. Ireland, A. Santos, F. Campbell, C. Figueiredo, L. Ellies, U. Weyer-Czernilofsky, T. Bogenrieder, M. Schmid, A. Mielgo
This study shows that blocking insulin-like growth factors enhances paclitaxel's effectiveness against metastatic breast cancer by reducing tumor growth and lung metastasis in pre-clinical models.
bioRxiv · Jul 23, 2017Cancer Biology